Liminal Biosciences Inc (LMNL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,242 | -35,956 | -91,175 | -155,809 | -183,537 |
| Depreciation Amortization | 862 | 3,466 | 6,306 | 7,465 | 4,211 |
| Income taxes - deferred | 220 | 94 | N/A | 66 | -10,658 |
| Other Working Capital | -32 | 1,136 | 843 | -10,926 | 8,771 |
| Other Operating Activity | -3,283 | -48,214 | 27,355 | 84,304 | 117,600 |
| Operating Cash Flow | $-24,476 | $-79,473 | $-56,672 | $-74,900 | $-63,613 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -192 | -622 | -2,066 | -2,921 |
| Net Acquisitions | 2,445 | 138,322 | 3,400 | 33,127 | N/A |
| Purchase Sale Intangibles | -5 | -136 | -806 | -1,283 | -1,035 |
| Other Investing Activity | 502 | -1,934 | -1,058 | -3,859 | -1,599 |
| Investing Cash Flow | $2,938 | $136,195 | $1,721 | $27,202 | $-4,520 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 23,539 | 14,966 | 61,030 |
| Debt Repayment | -30,093 | -3,148 | -123 | N/A | -2,457 |
| Common Stock Issued | N/A | N/A | 29,892 | 89,516 | 1,069 |
| Other Financing Activity | -4,864 | -3,574 | -10,456 | -15,618 | -3,972 |
| Financing Cash Flow | $-34,957 | $-6,722 | $42,853 | $88,864 | $55,670 |
| Exchange Rate Effect | 1,616 | 598 | -2 | -549 | 292 |
| Beginning Cash Position | 83,451 | 35,965 | 45,749 | 5,568 | 17,873 |
| End Cash Position | 28,571 | 86,564 | 33,649 | 46,184 | 5,701 |
| Net Cash Flow | $-54,879 | $50,599 | $-12,101 | $40,616 | $-12,172 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,476 | -79,473 | -56,672 | -74,900 | -63,613 |
| Capital Expenditure | -10 | -234 | -721 | -2,066 | -2,921 |
| Free Cash Flow | -24,486 | -79,707 | -57,393 | -76,966 | -66,534 |